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Abstract.  
We have synthesized of novel 2,3-polymethylenepyrido[2,3-d]pyrimidine-4-ones via condensation of the 2-aminonicotinic 
acid together with lactams in the presence of phosphorus oxychloride. The structures of the newly synthesized pyrido[2,3-
d]pyrimidines were confirmed by 
1
H and 
13
C NMR spectral data.   
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Introduction 
It is well known that the pyrido[2,3-d]pyrimidine derivatives are of great interest due to diverse biological activity including 
anticancer or antiproliferative activities [1-4] . This structural motif is present in Palbociclib (PD 0322991) which is an oral 
inhibitor of CDK4/6. Moreover, single-agent palbociclib is well tolerated and active in patients with endocrine-resistant, 
HR
+
, Rb-positive breast cancer [3]. There are many encouraging the representatives of high biological and 
pharmacological activities together with many other applications. On the other hand, the chemical structure of pyrido[2,3-
d]pyrimidines is attractive of chemists due to presenting many of reaction centers. That is why the synthetic methods for 
preparing of the new representatives of pyrido[2,3-d]pyrimidine series of compounds are increased [5]. Our group has 
been actively working on the development of synthetic strategies for the preparation of 2,3-polymethylene derivatives of 
condensed with thiophene and benzene cycles pyrimidines, i.e. thieno[2,3-d]- and benz[2,3-d]pyrimidin-4(1H)-ones 
(quinazolin-4-ones) and non-condensed pyrimidin-4-ones also [6-8]. As a continuation of our efforts to find new pyrido[2,3-
d]pyrimidines with further transformations we have synthesized novel 2,3-polymethylene-pyrido[2,3-d]-pyrimidin-4-ones.  
Results and Discussion. 
The following scheme outline the synthetic pathway used to obtain compounds described in this paper:  
N
O
OH
NH2
+
POCl3HN
(CH2)n
O n = 1,2,3 N
N
N
O
(CH2)n
 
Thus, heating of the 6-aminonicotinic acid with lactams (γ-butyrolactam, δ-valerolactam, and ε-caprolactam) in the 
presence of phosphorus oxychloride afforded to 2,3-polymethylene (tri-, tetra, and pentamethylene) pyrido[2,3-d]pyrimidin-
4(1H)-ones with satisfactory yields. Structures of the newly synthesized 2,3-tri(tetra-, and penta-)methylenepyrido[2,3-
d]pyrimidin-4(1H)-ones were evidenced on the basis of 
1
H NMR and 
13
C-NMR spectral data.  
The 
1
H-NMR (CDCl3) spectrum of 2,3-polymethylene pyrido[2,3-d]pyrimidin-4(1H)-ones showed aromatic proton signals at 
7.29-7.35 (1H, q, H-6), 7.47-7.54 (1H, dd, J=2.8Hz, H-5), and 8.85-8.89 (1H, dd, J=2-6Hz, H-7), which are characteristic 
for pyridine part of the molecules. 
It was observed shifting of β-methylene proton signals to more strong field of the 
1
H NMR spectrum at increasing of 
carbon atoms in polymethylene chain. If for 2,3-trimethylene derivative the β-methylene proton signals appeared at 2.2-2.3 
ppm as a multiplet, and in 2,3-tetramethylene derivative it appeared at 1.91-1.92 ppm, while for 2,3-pentamethylene the 
signal is overlapped with γ-methylene protons and appeared at 1.809-1.821 ppm. Similarly, chemical shifts of α-methylene 
proton signals appeared at 3.2 (trimethylene-derivative), 3.03 (tetramethylene-derivative), and 3.076-3.102 ppm 
(pentamethylene-derivative), respectively.  
Methylene protons' signals of neighboring to N3 nitrogen atom in all cases are appeared in weakly field and observed at 
4.16 (γ-CH2 of trimethylene), 4.00 (δ-CH2 of tetramethylene), and 4.298-4.322  
(ε-CH2 of pentamethylene-derivative), respectively.    
Moreover, the 
13
C-NMR spectrum showed characteristic signals at strong field for polymethylene part of the molecules. 
The carbonyl group's carbon atom and C-9 atoms of 2,3-polymethylenepyrido[2,3-d]pyrimidin-4(1H)-ones are observed at 
more weakly fields of the 
13
C-NMR spectrum.   
Experimental 
IR spectra of samples were taken in pressed KBr pellets on a PerkinElmer model 2000 IR-Fourier spectrometer. The NMR 
spectrums of 2,3-polymethylenepyrido[2,3-d]pyrimidin-4-ones were recorded in CDCl3 on a Varian 400-MR spectrometer 
at operating frequency 400MHz for 
1
H and 100 MHz for 
13
C. Chemical shifts are given on the δ scale. HMDSO is used as 
internal standard. Melting points were determined on Boethius apparatus and are uncorrected.  
Synthesis of 2,3-trimethylenepyrido[2,3-d]pyrimidin-4-one. General method. To the mixture of 2-aminonicotinic acid 
(3.335 g, 0.024 mol) and -butyrolactam (3.6 ml, 0.048 mol) was treated POCl3 (5.0ml, 0.54 mol). The obtained mixture 
was refluxed (about 160-170
0
C) during 2 hours. Water was added. Extracted by chloroform (3 times, 30mL). The solvent 
evaporated, re-crystallized from appropriate solvent.   
2,3-Trimethylenepyrido[2,3-d]pyrimidin-4-one. Yield: 38% of light-yellowish solid. M.p. 139-140
0
C. IR-spectrum (KBr, ν, 
cm
-1
): 3409 (weak), 3221, 2921, 2862, 1718, 1625, 1491, 1457, 1400, 1307, 1257. 
1
H NMR spectrum (400 MHz, CDCl3, δ, 
ppm, J/Hz):  2.2-2.3 (2H, m, β-CH2), 3.2 (2H, t, J=8, α-CH2),  4.16 (2H, t, J=7, γ-CH2), 7.3-7.35 (1H, q, H-6), 8.52-8.54 (1H, 
dd, J=2, 8, H-5), 8.87-8.89 (1H, dd, J=2, 6, H-7). 
13
C NMR spectrum of 2,3-trimethylenepyrido[2,3-d]pyrimidin-4-one (100 
MHz, CDCl3, δ, ppm):  19.483 (β-C), 32.962 (α-C), 46.883 (γ-C), 115.711 (C-10), 121.853 (C-6), 136.144 (C-5), 155.994 
(C-7), 159.428 (C-2), 161.226 (C-4), 163.351(C-9). LC-MS: 188 [M+H]
+
, (Rt = 3.794). 
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2,3-Tetramethylenepyrido[2,3-d]pyrimidin-4-one. Yield: 45% of yellow solid. M.p. 161-162
0
C. IR spectrum (KBr, ν, cm
-
1
): 2948, 2875, 1683, 1594, 1579, 1567, 1463, 1436, 1397. 
1
H NMR spectrum (400 MHz, CDCl3, δ, ppm, J/Hz):  1.91-1.92 
(2H, m, β-CH2), 1.98 (2H, m, γ-CH2), 3.03 (2H, t, J=7.3, α-CH2),  4.00 (2H, t, J=6.2, δ-CH2), 7.29-7.32 (1H, q, H-6), 8.49-
8.51 (1H, dd, J=2, 8, H-5), 8.86-8.87 (1H, dd, J=2, 4.6, H-7). 
13
C NMR spectrum (100 MHz, CDCl3, δ, ppm, J/Hz):  19.225 
(β-C), 22.001 (γ-C), 32.294 (α-C), 42.809 (δ-C), 115.353 (C-10), 121.702 (C-6), 136.217 (C-5), 156.190 (C-7), 157.427 (C-
2), 158.748 (C-4), 162.617 (C-9). DEPT spectrum shows seven protonated carbon atoms.   
2,3-Pentamethylenepyrido[2,3-d]pyrimidin-4(1H)-one. Yield: 30% of brown solid. M.p. 119-120
0
C. IR spectrum (KBr, ν, 
cm
-1
): 3442, 2934, 2859, 1722, 1681, 1596, 1586, 1568, 1438, 1395, 1350. 
1
H NMR spectrum of 2,3-
pentamethylenepyrido[2,3-d]pyrimidin-4-one (400MHz, CDCl3, δ, ppm, J/Hz): 1.809-1.821 (6H, m, β, γ, δ-CH2), 3.076-
3.102 (2H, t, α-CH2), 4.298-4.322 (2H, t, ε-CH2), 7.295-7.326 (1H, q, H-6), 8.469-8.494 (1H, dd, J=2, 8, H-5), 8.850-8.861 
(1H, dd, J=2, 6, H-7). 
13
C NMR spectrum of 2,3-pentamethylenepyrido[2,3-d]pyrimidin-4-one (100MHz, CDCl3, δ, ppm): 
25.129, 27.945, and 29.564 (carbon atoms of three methylenes at β, γ, δ-positions), 37.928 (α-C), 43.235 (ε-C), 121.979 
(C-6), 136.575 (C-5), 156.061 (C-7), 115.233 (C-10), 157.445 (C-2), 162.290 (C-4), 163.480 (C-9).  
DEPT shows 8 protonated C atoms.  
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